Multiple Myeloma Hub‘s summary of the iStopMM key talks and posters at ASH 2021

Researchers at iStopMM have for the first time described the prevalence of smoldering multiple myeloma and the findings indicate that it is present in 0.5%

In an article in CancerTherapyAdvisor.com the iStopMM study and it‘s results are covered. Results from the study were presented at the 2021 American Society of

Sigurður Yngvi Kristinsson, principal investigator of iStopMM, received a large project grant from the Icelandic Centre for Research (RANNIS) for the next three years for